StockDuty ← Dashboard Nov 03, 2026 04:26 PM ET
SignalIndia

Emcure Pharma Q2 Results: Profit jumps 29% to Rs 325 crore

Profit jumps 29% to Rs 325 crore signals strong Q2 earnings growth.

What happened: Emcure Pharmaceuticals reported a 29 percent rise in Q2 profit to Rs 325 crore, up from Rs 251.37 crore a year earlier, according to a regulatory filing. Key numbers: Profit Rs 325 crore vs Rs 251.37 crore. Revenue Rs 2,820.47 crore vs Rs 2,269.82 crore. Total expenses Rs 2,377.87 crore vs Rs 1,931.52 crore. International business up 34 percent to Rs 1,665.2 crore. Why it matters: Chairman, Managing Director and CEO Satish Mehta said Q2 showed broad-based growth in revenue, profitability and earnings, and that the company expects business momentum to sustain into H2FY27.
Emcure Pharmaceuticals reported a 29 percent rise in Q2 profit to Rs 325 crore, up from Rs 251.37 crore a year earlier, according to a regulatory filing.
Chairman, Managing Director and CEO Satish Mehta said Q2 showed broad-based growth in revenue, profitability and earnings, and that the company expects business momentum to sustain into H2FY27.
Sources